Involvement of the Immune System in Idiosyncratic Drug Reactions

被引:44
作者
Zhang, Xiachu [1 ]
Liu, Feng [1 ]
Chen, Xin [1 ]
Zhu, Xu [1 ]
Uetrecht, Jack [1 ]
机构
[1] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada
基金
加拿大健康研究院;
关键词
idiosyncratic drug reactions; drug-induced liver injury; autoimmunity; hapten hypothesis; danger hypothesis; mitochondrial injury; INDUCED LIVER-INJURY; GROUP BOX-1 PROTEIN; INDUCED AGRANULOCYTOSIS; ALLERGIC REACTIONS; DANGER HYPOTHESIS; COVALENT BINDING; DNA METHYLATION; INDUCED LUPUS; ANIMAL-MODEL; T-CELLS;
D O I
10.2133/dmpk.DMPK-10-RV-085
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is strong evidence that most idiosyncratic drug reactions (IDRs) are immune-mediated and are caused by reactive metabolites of a drug rather than by the drug itself. Several hypotheses have been proposed by which a drug could induce an immune response. The major hypotheses are the hapten hypothesis and the danger hypothesis; however, the characteristics and spectrum of IDRs are different with different drugs, and this likely reflects mechanistic differences; therefore, no one hypothesis is likely to explain all IDRs. Some IDRs appear to involve epigenetic effects, direct activation of antigen-presenting cells, or disturbing the normal balance of the immune system. It has been suggested that many cases of idiosyncratic liver injury are not immune-mediated, and other mechanisms such as mitochondria(injury may be involved. It is essential that any hypothesis be consistent with the clinical characteristics of the IDR. Although the characteristics of most idiosyncratic liver injury do not suggest that mitochondria are the major target, it is quite possible that milder mitochondrial injury could stimulate an immune-mediated reaction. The observation that IDRs can vary widely among different drugs and different patients is most easily explained by an immune mechanism in which the target of the immune response is different.
引用
收藏
页码:47 / 59
页数:13
相关论文
共 134 条
[1]   Toxic epidermal necrolysis and Stevens-Johnson syndrome: Soluble Fas ligand involvement in the pathomechanisms of these diseases [J].
Abe, Riichiro .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2008, 52 (03) :151-159
[2]   Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity [J].
Akamizu, T ;
Ozaki, S ;
Hiratani, H ;
Uesugi, H ;
Sobajima, J ;
Hataya, Y ;
Kanamoto, N ;
Saijo, M ;
Hattori, Y ;
Moriyama, K ;
Ohmori, K ;
Nakao, K .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (01) :92-98
[3]   Idiosyncratic drug-induced agranulocytosis:: Update of an old disorder [J].
Andres, Emmanuel ;
Zimmer, Jacques ;
Affenberger, Stephane ;
Federici, Laure ;
Alt, Martine ;
Maloisel, Frederic .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2006, 17 (08) :529-535
[4]  
[Anonymous], CHEM RES TOXICO 0617
[5]  
[Anonymous], J IMMUNOTOXICOL
[6]  
[Anonymous], SYSTEMIC LUPUS ERYTH
[7]   High-Mobility Group Box-1 Protein and Keratin-18, Circulating Serum Proteins Informative of Acetaminophen-Induced Necrosis and Apoptosis In Vivo [J].
Antoine, Daniel J. ;
Williams, Dominic P. ;
Kipar, Anja ;
Jenkins, Rosalind E. ;
Regan, Sophie L. ;
Sathish, Jean G. ;
Kitteringham, Neil R. ;
Park, B. Kevin .
TOXICOLOGICAL SCIENCES, 2009, 112 (02) :521-531
[8]  
Aster RH, 2000, SEMIN HEMATOL, V37, P229
[9]   Current concepts - Drug-induced immune thrombocytopenia [J].
Aster, Richard H. ;
Bougie, Daniel W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (06) :580-587
[10]  
Aster Richard H, 2010, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-642-00663-0_3